DNurse
Latest round
- Series A
Last raised
- Feb 2015
Total raised
- $0.5M
Investors
- 3
About DNurse
DNurse, established in 2013, operates in Beijing, China, providing a comprehensive platform for diabetes management. The company recently transitioned to be a subsidiary of ETA International Group after acquisition in October 2021. Jason Li leads the company, having previously founded other technology ventures.DNurse offers a diabetes management platform that integrates smart medical devices, mobile applications, and intelligent management services to empower patients in self-managing their condition. Key offerings include glucose monitoring systems and insulin injection data collection, which upload data to the DNurse mobile application for real-time access by healthcare providers.The company generates revenue via a direct-to-consumer model, providing subscriptions for its mobile application and services. Patients benefit from ongoing analysis, personalized guidance, and monitoring features as part of their diabetes management plan.DNurse plans to enhance its product offering with new smart devices and mobile app features that are expected to launch in the upcoming year. Additionally, the company aims to expand into new markets across Southeast Asia by 2023.
Who invested in DNurse
3 investors across 2 rounds
See all investors in DNurse
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about DNurse
Who invested in DNurse?
DNurse has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has DNurse raised?
DNurse has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did DNurse last raise money?
DNurse's most recent round on record is a Series A, in Feb 2015.
What does DNurse do?
DNurse, established in 2013, operates in Beijing, China, providing a comprehensive platform for diabetes management.
Where is DNurse headquartered?
DNurse is headquartered in Beijing, China.
Which VCs invest in companies like DNurse?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, Taibao Capital and Hengxu Capital back healthcare companies at DNurse's stage. Their profiles are linked below.
VCs backing healthcare startups at Series A
Raising like DNurse? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.